Cargando…

Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia

Glucose and lipid metabolism are linked to each other in many ways. The most important clinical manifestation of this interaction is diabetic dyslipidemia, characterized by elevated triglycerides, low high density lipoprotein cholesterol (HDL-C), and predominance of small-dense LDL particles. Howeve...

Descripción completa

Detalles Bibliográficos
Autor principal:	Parhofer, Klaus G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Diabetes Association 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641964/ https://www.ncbi.nlm.nih.gov/pubmed/26566492 http://dx.doi.org/10.4093/dmj.2015.39.5.353

Ejemplares similares

Review of extended-release niacin/laropiprant fixed combination in the treatment of mixed dyslipidemia and primary hypercholesterolemia
por: Parhofer, Klaus G
Publicado: (2009)

Diabetes and Familial Hypercholesterolemia: Interplay between Lipid and Glucose Metabolism
por: González-Lleó, Ana M., et al.
Publicado: (2022)

Diabetes and dyslipidemia: characterizing lipoprotein metabolism
por: Tomkin, GH, et al.
Publicado: (2017)

Polymorphisms of lipid metabolism enzyme-coding genes in patients with diabetic dyslipidemia
por: Vardarlı, Aslı Tetik, et al.
Publicado: (2017)

Is There More to Olive Oil than Healthy Lipids?
por: Isaakidis, Akritas, et al.
Publicado: (2023)

Diabetes Dyslipidemia
por: Schofield, Jonathan D., et al.
Publicado: (2016)

More Than an Antioxidant: Role of Dietary Astaxanthin on Lipid and Glucose Metabolism in the Liver of Rainbow Trout (Oncorhynchus mykiss)
por: Kalinowski, Carmen Tatiana, et al.
Publicado: (2023)

The Role of Food Peptides in Lipid Metabolism during Dyslipidemia and Associated Health Conditions
por: Udenigwe, Chibuike C., et al.
Publicado: (2015)

Advances in HDL: Much More than Lipid Transporters
por: Ben-Aicha, Soumaya, et al.
Publicado: (2020)

SGLT2 Inhibitors in the Treatment of Diabetic Kidney Disease: More than Just Glucose Regulation
por: Klen, Jasna, et al.
Publicado: (2023)

Oral Lipid-Lowering Treatments Beyond Statins: Too Old and Outdated or Still Useful?
por: Parhofer, Klaus G.
Publicado: (2021)

Pathophysiology of Diabetic Dyslipidemia
por: Hirano, Tsutomu
Publicado: (2018)

Nutrigenetic Contributions to Dyslipidemia: A Focus on Physiologically Relevant Pathways of Lipid and Lipoprotein Metabolism
por: Hannon, Bridget A., et al.
Publicado: (2018)

Dietary Lipids and Dyslipidemia in Chronic Kidney Disease
por: Kochan, Zdzislaw, et al.
Publicado: (2021)

Lipid-Lowering Nutraceuticals for an Integrative Approach to Dyslipidemia
por: Cheung, Brian, et al.
Publicado: (2023)

The more critical murderer of atherosclerosis than lipid metabolism: chronic stress
por: Meng, Ling-bing, et al.
Publicado: (2018)

Dyslipidemia in retinal metabolic disorders
por: Fu, Zhongjie, et al.
Publicado: (2019)

Sirtuins in glucose and lipid metabolism
por: Ye, Xin, et al.
Publicado: (2016)

Adipokines in glucose and lipid metabolism
por: Wang, Xueqing, et al.
Publicado: (2023)

Diabetes mellitus in Zeiten von COVID-19
por: Parhofer, Klaus G.
Publicado: (2021)

Diabetes mellitus in Zeiten von COVID-19
por: Parhofer, Klaus G.
Publicado: (2021)

Predictors of glucose control in children and adolescents with type 1 diabetes: results of a cross-sectional study in Cameroon
por: Niba, Loveline L., et al.
Publicado: (2017)

Fructose, insulin resistance, and metabolic dyslipidemia
por: Basciano, Heather, et al.
Publicado: (2005)

More Than Meets the Eye Regarding Cancer Metabolism
por: Kubicka, Anna, et al.
Publicado: (2021)

Association Between the Awareness of Dyslipidemia and Health Behavior for Control of Lipid Levels Among Korean Adults with Dyslipidemia
por: Cho, In Young, et al.
Publicado: (2017)

The Diabetes Mellitus–Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation
por: Poznyak, Anastasia, et al.
Publicado: (2020)

Glucose metabolism responds to perceived sugar intake more than actual sugar intake
por: Park, Chanmo, et al.
Publicado: (2020)

The Lipid Profiles in Different Characteristics of Women with PCOS and the Interaction Between Dyslipidemia and Metabolic Disorder States: A Retrospective Study in Chinese Population
por: Guo, Fei, et al.
Publicado: (2022)

The Interactions of Insulin and Vitamin A Signaling Systems for the Regulation of Hepatic Glucose and Lipid Metabolism
por: Chen, Guoxun
Publicado: (2021)

Diabetic macular edema: it is more than just VEGF
por: Singer, Michael A., et al.
Publicado: (2016)

Mipomersen: evidence-based review of its potential in the treatment of homozygous and severe heterozygous familial hypercholesterolemia
por: Parhofer, Klaus G
Publicado: (2012)

The interaction between ferroptosis and lipid metabolism in cancer
por: Li, Dingshan, et al.
Publicado: (2020)

Effects of the New Dual PPARα/δ Agonist GFT505 on Lipid and Glucose Homeostasis in Abdominally Obese Patients With Combined Dyslipidemia or Impaired Glucose Metabolism
por: Cariou, Bertrand, et al.
Publicado: (2011)

ANGPTL8 in metabolic homeostasis: more friend than foe?
por: Guo, Chang, et al.
Publicado: (2021)

Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
por: Tenenbaum, Alexander, et al.
Publicado: (2006)

Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment
por: Halpern, Alfredo, et al.
Publicado: (2010)

Role of mTOR in Glucose and Lipid Metabolism
por: Mao, Zhuo, et al.
Publicado: (2018)

CREBH Regulates Systemic Glucose and Lipid Metabolism
por: Nakagawa, Yoshimi, et al.
Publicado: (2018)

Roles of Twist1 in lipid and glucose metabolism
por: Huang, Liuyifei, et al.
Publicado: (2023)

Aloe vera in diabetic dyslipidemia: Improving blood glucose and lipoprotein levels in pre-clinical and clinical studies
por: Deora, Neha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2v03ik3gh0a87pmav5c95t2ddp